Current Management of Secondary Hyperparathyroidism: a Multicenter Observational Study (COSMOS)
Jorge B. Cannata‐Andía(Universidad de Oviedo), Mihael Benedik(Ljubljana University Medical Centre), Willem Jan W. Bos(St. Antonius Ziekenhuis), Dimitrios Memmos, Adrian Covic(Grigore T. Popa University of Medicine and Pharmacy), José Luis Górriz(Universitat de València), Carmine Zoccali(Biogem), Vladimı́r Teplan(Institute of Clinical and Experimental Medicine), Reinhard Kramar(Statistics Austria), Rudolf P. Wüthrich(University of Zurich), Pierre‐Yves Martin(University Hospital of Geneva), Dierik Verbeelen(Vrije Universiteit Brussel), Jürgen Floege(University of Göttingen), Christian Tielemans(Vrije Universiteit Brussel), Judit Nagy(University of Pecs), David J A Goldsmith(Guy's and St Thomas' NHS Foundation Trust), Draško Pavlović
Cited by 34
Related Papers
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
|The Lancet|2001|1.1k
Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria
|The Lancet|1999|909
A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases
|Kidney International|2019|886
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877